Published in Cochrane Database Syst Rev on September 12, 2012
Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. CMAJ (2013) 1.82
Mild cognitive impairment: a concept in evolution. J Intern Med (2014) 1.65
The diagnosis and management of mild cognitive impairment: a clinical review. JAMA (2014) 1.18
Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med (2014) 1.03
Nicotinic receptors in neurodegeneration. Curr Neuropharmacol (2013) 0.91
Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments. Curr Psychiatry Rep (2014) 0.89
Alzheimer Disease. Continuum (Minneap Minn) (2016) 0.83
Treatment for mild cognitive impairment: a systematic review and meta-analysis. CMAJ Open (2015) 0.81
Neuropsychiatric Symptoms in Mild Cognitive Impairment. Can J Psychiatry (2017) 0.79
Cholinergic Enhancement of Brain Activation in Mild Cognitive Impairment during Episodic Memory Encoding. Front Psychiatry (2013) 0.76
Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis (2015) 0.76
Diagnostic tools for alzheimer's disease dementia and other dementias: an overview of diagnostic test accuracy (DTA) systematic reviews. BMC Neurol (2014) 0.76
Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support. Neurochem Int (2017) 0.75
The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med (2016) 0.75
ACP Journal Club. Review: cholinesterase inhibitors do not reduce progression to dementia from mild cognitive impairment. Ann Intern Med (2013) 0.75
The role of cognitive activity in cognition protection: from Bedside to Bench. Transl Neurodegener (2017) 0.75
Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia. Curr Neuropharmacol (2016) 0.75
Little evidence that cholinesterase inhibitors prevent progression of mild cognitive impairment to dementia, but they are associated with adverse effects. Evid Based Ment Health (2013) 0.75
Developing a Non-Pharmacological Intervention for Individuals With Mild Cognitive Impairment. J Appl Gerontol (2016) 0.75
Chronic Heart Failure Care Planning: Considerations in Older Patients. Card Fail Rev (2017) 0.75
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study. PLoS One (2017) 0.75
Socioeconomic deprivation increases the effect of winter on admissions to hospital with COPD: retrospective analysis of 10 years of national hospitalisation data. Prim Care Respir J (2013) 1.60
Is there a divergence in time trends in the prevalence of impaired glucose tolerance and diabetes? A systematic review in South Asian populations. Int J Epidemiol (2011) 1.54
Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care (2013) 0.99
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study. J Hepatol (2013) 0.94
Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2013) 0.91
Oral vasodilators for primary Raynaud's phenomenon. Cochrane Database Syst Rev (2012) 0.82
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes. Diabetologia (2015) 0.82
N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia (2014) 0.78
Attitudes to shared care for patients with dementia: a survey of general practitioners. Dementia (London) (2012) 0.76
Padma 28 for intermittent claudication. Cochrane Database Syst Rev (2016) 0.75